GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Wiley ; 2009
    In:  Journal of Inherited Metabolic Disease Vol. 32, No. 1 ( 2009-02), p. 22-26
    In: Journal of Inherited Metabolic Disease, Wiley, Vol. 32, No. 1 ( 2009-02), p. 22-26
    Abstract: The value of genotyping to identify tetrahydrobiopterin‐responsive (BH 4 ‐responsive) patients with phenylalanine hydroxylase (PAH) deficiency is a matter of debate. Methods We reviewed 250 cases of patients with PAH deficiency, using published data from 198 cases and unpublished data from 52 cases of patients attending our own clinic. Patients underwent analyses for BH 4 load and genetic mutations. Partial and full BH 4 responses were defined as a 10–29% decrease and a ≥30% decrease from baseline in blood phenylalanine levels, respectively. BH 4 ‐responsive alleles were identified from BH 4 ‐responsive patients as either homozygous for a specific allele or compound heterozygous for that allele with a null mutation. Results Most inconsistencies between observed genotype and BH 4 response were associated with mutations in the regulatory domain of PAH (p.R68S, p.I65T, p.L48S and p.F39C), where 20/62 alleles (32.2%) were non‐responsive. In the catalytic domain (mutations p.Y414C, p.R261Q, p.E390G, p.A300S, p.R241C, p.A403V and p.V388M), only 8/125 alleles (6.4%) were non‐responsive. Seven patients had a genotype with two BH 4 ‐responsive alleles resulting in no response or only a partial response to BH 4 . Ten patients had identical genotypes but inconsistent responses in BH 4 load. Conclusions These results show that BH 4 non‐responsiveness is associated with genotype. However, patients with mutations in the regulatory domain show inconsistent results. In patients with two responsive alleles, non‐responsiveness may be related to negative inter‐allelic complementation. In patients with the same genotype and inconsistent results for BH 4 load, external factors such as intestinal absorption of BH 4 , catabolic conditions or other genetic factors may be responsible. Further in vitro studies are necessary to clarify the genotype–phenotype correlation in patients with BH 4 ‐responsive PKU.
    Type of Medium: Online Resource
    ISSN: 0141-8955 , 1573-2665
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2009
    detail.hit.zdb_id: 2006875-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 1996
    In:  European Journal of Pediatrics Vol. 155, No. 5 ( 1996-5), p. 423-424
    In: European Journal of Pediatrics, Springer Science and Business Media LLC, Vol. 155, No. 5 ( 1996-5), p. 423-424
    Type of Medium: Online Resource
    ISSN: 0340-6199 , 1432-1076
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 1996
    detail.hit.zdb_id: 2647723-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 1992
    In:  European Journal of Pediatrics Vol. 151, No. 9 ( 1992-9), p. 688-692
    In: European Journal of Pediatrics, Springer Science and Business Media LLC, Vol. 151, No. 9 ( 1992-9), p. 688-692
    Type of Medium: Online Resource
    ISSN: 0340-6199 , 1432-1076
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 1992
    detail.hit.zdb_id: 2647723-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Wiley ; 2010
    In:  Journal of Inherited Metabolic Disease Vol. 33, No. S3 ( 2010-12), p. 163-169
    In: Journal of Inherited Metabolic Disease, Wiley, Vol. 33, No. S3 ( 2010-12), p. 163-169
    Abstract: Treatment with tetrahydrobiopterin (BH 4 ), the natural cofactor of phenylalanine hydroxylase (PAH), can reduce blood phenylalanine (Phe) levels in patients with BH 4 ‐responsive phenylketonuria (PKU). A number of studies has reported on the short‐term BH 4 treatment of patients with PKU, but long‐term data are lacking. Here, we describe the effects of long‐term treatment with BH 4 on 16 patients, who showed a 〉 28% reduction in blood Phe following testing for BH 4 overload. The mean dose of BH 4 was 16 mg/kg body weight (range 5–36 mg/kg body weight). The mean treatment duration was 56 months (range 24–110 months). Of 16 patients, 14 achieved long‐term Phe control with BH 4 treatment, with a mean blood Phe concentration of 321 ± 236 µmol/l. The mean decrease from baseline in blood Phe levels in these 14 patients was 54.6%. Of the seven patients who required continued dietary restriction, Phe intake increased from 200–300 mg/day to 800–1000 mg/day. Factors that may cause fluctuation of Phe levels in BH 4 ‐treated patients include patients’ PAH genotype, Phe intake, changes in protein catabolism or anabolism, and periods of illness or infection.
    Type of Medium: Online Resource
    ISSN: 0141-8955 , 1573-2665
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2006875-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...